REQUEST A DEMO
Total
USD $0.00
Search more companies

Kobiolabs, Inc (South Korea)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Kobiolabs, Inc Profile Updated: July 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The Company is a Korea-based company mainly engaged in the development and sales of functional probiotics. The Company s products are sold under the names of Bioviom and Queens henna FOODOLOGY. The Company is also engaged in the development of new microbiome drugs. In addition, the Company engages in commissioned research. The Company sells its products in domestic and overseas markets. The Company was established on August 11, 2014. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on November 11, 2020.

Headquarters
628, 220 Dong, Research Institute Of Bio
Seoul; Seoul;

Contact Details: Purchase the Kobiolabs, Inc report to view the information.

Website: http://kobiolabs.com

Basic Information
Total Employees:
Purchase the Kobiolabs, Inc report to view the information.
Outstanding Shares:
Purchase the Kobiolabs, Inc report to view the information.
Registered Capital:
Purchase the Kobiolabs, Inc report to view the information.
Financial Auditors:
Purchase the Kobiolabs, Inc report to view the information.
Incorporation Date:
August 11, 2014
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Subsidiaries
Kobiolabs Australia Pty Ltd
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
No results were found for this company.

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?